Bruce A. Malcolm

Person

Westfield, NJ, US

People

Patents Grantslast 30 patents

Information Patent Grant
Refolded recombinant β-secretase crystals and methods for preparing...
- Patent number 8,063,185
- Issue date Nov 22, 2011
- Schering Corp.
- Brian M. Beyer
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Treatments for Flaviviridae virus infection
- Patent number 7,816,339
- Issue date Oct 19, 2010
- Schering Corporation
- Bruce A. Malcolm
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical formulations and methods of treatment using the same
- Patent number 7,772,178
- Issue date Aug 10, 2010
- Schering Corporation
- Bruce A. Malcolm
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for making β-secretase co-crystals complexed with a ligand
- Patent number 7,569,391
- Issue date Aug 4, 2009
- Schering Corporation
- Brian M. Beyer
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Treatments for Flaviviridae virus infection
- Patent number 7,524,831
- Issue date Apr 28, 2009
- Schering Corporation
- Bruce A. Malcolm
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Codon-optimized β-secretase and methods of refolding and processing
- Patent number 7,166,454
- Issue date Jan 23, 2007
- Schering Corporation
- Brian M. Beyer
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Diaryl peptides as NS3-serine protease inhibitors of hepatitis C virus
- Patent number 6,911,428
- Issue date Jun 28, 2005
- Schering Corporation
- Zhaoning Zhu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Single-chain recombinant complexes of hepatitis C virus NS3 proteas...
- Patent number 6,653,127
- Issue date Nov 25, 2003
- Schering Corporation
- Bruce A. Malcolm
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Peptide substrates for HCV NS3 protease assays
- Patent number 6,251,583
- Issue date Jun 26, 2001
- Schering Corporation
- Rumin Zhang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Single-chain recombinant complexes of hepatitis C virus NS3 proteas...
- Patent number 6,211,338
- Issue date Apr 3, 2001
- Schering Corporation
- Bruce A. Malcolm
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
TREATMENTS FOR FLAVIVIRIDAE VIRUS INFECTION
- Publication number 20110033422
- Publication date Feb 10, 2011
- Schering Corporation
- Bruce A. Malcolm
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
REFOLDED RECOMBINANT ALPHA SECRETASE CRYSTALS AND METHODS FOR PREPA...
- Publication number 20100203616
- Publication date Aug 12, 2010
- Schering Corp.
- Brian M. Beyer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TREATMENTS FOR FLAVIVIRIDAE VIRUS INFECTION
- Publication number 20090209483
- Publication date Aug 20, 2009
- Schering Corporation
- Bruce A. Malcolm
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Combinations comprising HCV protease inhibitor(s) and HCV polymeras...
- Publication number 20070274951
- Publication date Nov 29, 2007
- Xiao Tong
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Controlled-release formulation of HCV protease inhibitor and method...
- Publication number 20070237818
- Publication date Oct 11, 2007
- Bruce A. Malcolm
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Novel HCV inhibitor combinations and methods
- Publication number 20070224167
- Publication date Sep 27, 2007
- Schering Corporation
- Emillo Anthony Emini
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Refolded recombinant beta-secretase crystals and methods for prepar...
- Publication number 20070099273
- Publication date May 3, 2007
- Brian M. Beyer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Pharmaceutical formulations and methods of treatment using the same
- Publication number 20070010431
- Publication date Jan 11, 2007
- Schering Corporation
- Bruce A. Malcolm
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Method of treating interferon non-responders using HCV protease inh...
- Publication number 20070004635
- Publication date Jan 4, 2007
- Schering Corporation
- Janice K. Albrecht
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Asymmetric dosing methods
- Publication number 20060287248
- Publication date Dec 21, 2006
- Schering Corporation
- Bruce A. Malcolm
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Method for modulating activity of HCV protease through use of a nov...
- Publication number 20060281689
- Publication date Dec 14, 2006
- Schering Corporation
- Bruce A. Malcolm
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods of treating hepatitis C virus
- Publication number 20060276406
- Publication date Dec 7, 2006
- Schering Corporation
- Samir K. Gupta
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Controlled-release formulation
- Publication number 20060275366
- Publication date Dec 7, 2006
- Schering Corporation
- Bruce A. Malcolm
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Compounds for inhibiting cathepsin activity
- Publication number 20060252698
- Publication date Nov 9, 2006
- Bruce A. Malcolm
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Treatments for flaviviridae virus infection
- Publication number 20060198824
- Publication date Sep 7, 2006
- Schering Corporation
- Bruce A. Malcolm
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Pharmaceutical formulations
- Publication number 20060030550
- Publication date Feb 9, 2006
- Theodore L. Lithgow
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Continuous non-radioactive polymerase assay
- Publication number 20040142322
- Publication date Jul 22, 2004
- Schering Corporation
- Bruce A. Malcolm
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Combination therapy for RNA virus infections involving ribavirin an...
- Publication number 20040034206
- Publication date Feb 19, 2004
- Schering Corporation
- Bruce A. Malcolm
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Diaryl peptides as NS3-serine protease inhibitors of hepatitis C virus
- Publication number 20020147139
- Publication date Oct 10, 2002
- Schering Corporation
- Zhaoning Zhu
- C07 - ORGANIC CHEMISTRY

Bruce A. Malcolm

Person

Patents Grantslast 30 patents

Refolded recombinant β-secretase crystals and methods for preparing...

Treatments for Flaviviridae virus infection

Pharmaceutical formulations and methods of treatment using the same

Method for making β-secretase co-crystals complexed with a ligand

Treatments for Flaviviridae virus infection

Codon-optimized β-secretase and methods of refolding and processing

Diaryl peptides as NS3-serine protease inhibitors of hepatitis C virus

Single-chain recombinant complexes of hepatitis C virus NS3 proteas...

Peptide substrates for HCV NS3 protease assays

Single-chain recombinant complexes of hepatitis C virus NS3 proteas...

Patents Applicationslast 30 patents

TREATMENTS FOR FLAVIVIRIDAE VIRUS INFECTION

REFOLDED RECOMBINANT ALPHA SECRETASE CRYSTALS AND METHODS FOR PREPA...

TREATMENTS FOR FLAVIVIRIDAE VIRUS INFECTION

Combinations comprising HCV protease inhibitor(s) and HCV polymeras...

Controlled-release formulation of HCV protease inhibitor and method...

Novel HCV inhibitor combinations and methods

Refolded recombinant beta-secretase crystals and methods for prepar...

Pharmaceutical formulations and methods of treatment using the same

Method of treating interferon non-responders using HCV protease inh...

Asymmetric dosing methods

Method for modulating activity of HCV protease through use of a nov...

Methods of treating hepatitis C virus

Controlled-release formulation

Compounds for inhibiting cathepsin activity

Treatments for flaviviridae virus infection

Pharmaceutical formulations

Continuous non-radioactive polymerase assay

Combination therapy for RNA virus infections involving ribavirin an...

Diaryl peptides as NS3-serine protease inhibitors of hepatitis C virus